Matt Martin, PharmD, BCSCP, explores current developments in the peptide space and what pharmacists need to know amid FDA decision-making processes. Interest in peptides is growing among both patients ...

Throughout October, key recognition dates highlight the profession’s diverse workforce, including National Student ...

The necessity of centering equity on community needs is a global phenomenon. A joint study by the Sabin Vaccine Institute and ...

At eligible safety-net organizations, the 340B Drug Pricing Program may also support access. However, discounted acquisition costs do not establish a patient’s final charge. Pharmacists should confirm ...

Infectious disease readiness depends on rehearsed workflows, bidirectional public health communication, and rapid access to care. An infectious disease response does not begin when the first ...

The novel tool can be used to inform vaccine policy, monitor impact, and essentially strengthen overall surveillance. A novel approach to tracking pneumococcal disease could be on the horizon, ...

Melissa McGivney, PharmD, FAPhA, FCCP, discusses her career journey from her local pharmacy to a national leadership role with the American Pharmacists Association. From frontline clinical ...

In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy. Independent community ...

Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity. Retatrutide is an investigational, once weekly, first-in-class triple hormone ...

A case shows a suspected recurrence of pneumococcal disease that ended with removal of one cochlear implant and replacement of the other. The boy's history included recurrent otitis media and inner ...